ALLMedicine™ Acute Megakaryoblastic Leukemia Center
Research & Reviews 76 results
https://doi.org/10.1007/s12185-020-03066-7 10.1182/blood-2008-11-163501 10.1182/blood-2007-01-069542 10.1182/blood-2005-06-2448 10.1182/blood-2007-10-118810 10.1111/j.1365-2141.2008.07231.x 10.1182/blood.V80.6.1521.1521 10.1016/0046-8177(91)90111-2 10.1007/s12185-013-1487-5 10.1111/bjh.15390 10.1182/blood-2003-02-0390 10.1182/blood-2010-05-282426 10.1038/bmt.2012.244 10.1182/blood-2013-07-515148 10.1002/ajmg.a.61748
International Journal of Hematology; Yamato G, Park MJ et. al.
Jan 5th, 2021 - Transient abnormal myelopoiesis (TAM) is a unique clonal myeloproliferation characterized by immature megakaryoblasts that occurs in 5-10% of neonates with Down syndrome (DS). Although TAM regresses spontaneously in most patients, approximately 20...
https://doi.org/10.1016/j.clml.2020.11.001
Clinical Lymphoma, Myeloma & Leukemia; Wang Y, Lu A et. al.
Dec 2nd, 2020 - Acute megakaryoblastic leukemia (AMKL) is a biologically heterogeneous subtype of acute myeloid leukemia that originates from megakaryocytes. Patients with AMKL with non-Down syndrome (DS) had a poorer prognosis. However, clear prognostic indicato...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155101
Cancer Gene Therapy; Vukadin L, Kim JH et. al.
Nov 29th, 2020 - A high incidence of acute megakaryoblastic leukemia (AMKL) in Down syndrome patients implies that chromosome 21 genes have a pivotal role in AMKL development, but the functional contribution of individual genes remains elusive. Here, we report tha...
https://doi.org/10.1097/MPH.0000000000001986
Journal of Pediatric Hematology/oncology; Feng J, Leung AWK et. al.
Oct 31st, 2020 - There is no established effective treatment for patients with t(1;22)(p13;q13) acute megakaryoblastic leukemia (AMKL) and hepatic fibrosis. Here we report the outcomes of 2 t(1;22)(p13;q13) AMKL patients with hepatic fibrosis. One patient died fro...
https://doi.org/10.1002/cyto.b.21943
Cytometry. Part B, Clinical Cytometry; Panda D, Chatterjee G et. al.
Sep 1st, 2020 - In 2016, Children Oncology Group (COG) described a new high-risk subtype of acute myeloid leukemia (AML) with a distinct immunophenotypic-signature, RAM-phenotype (RAM-AML). Data on clinical and laboratory features of RAM-AML are still limited to ...
News 1 results
https://www.mdedge.com/hematology-oncology/article/186901/leukemia-myelodysplasia-transplantation/new-recommendations-pediatric-amkl
HT Staff
Jan 24th, 2017 - Micrograph showing AMKL Image courtesy of St. Jude Children’s Research Hospital and Tina Motroni Research has revealed genetic alterations that may prove useful for predicting treatment outcomes in pediatric patients with acute megakaryoblastic le.
